US approves Remdesivir as first treatment for COVID-19

‘We just ran’: the drama of families fleeing the war in Ethiopia

More than 40,000 people fled the fighting in the rebel region of Tigray. Most came to Sudan, walking through the desert. Most...

Donald Trump, ignored by the Pentagon, who refuses to grant a mining permit in Alaska

The decision is a major victory for environmental organizations, as well as Alaska Native people, who have opposed the Pebble Mine project for more...

China’s main wholesale market bans the sale of frozen products due to COVID-19 cases

The main wholesale market in Beijing, Xinfadi, the focus of a covid outbreak last June, has suspended the storage and sale of frozen and...

What is Moscow’s problem with Jehovah’s Witnesses?

Russian authorities raided and arrested several members of Jehovah's Witnesses in Moscow and twenty other regions. An investigation has been launched into the...

Largest number of corona deaths in six months in US on eve of Thanksgiving

In the past 24 hours, on the eve of Thanksgiving, the United States has recorded the highest number of corona deaths per day in...

The United States Food and Drug Administration (FDA) granted final approval as the first treatment for COVID-19 to the antiviral of Gilead Remdesivir, to date the only one with authorization from the regulator to treat the disease.

In May the antiviral de Gilead Sciences received the emergency authorization, a formula to allow the use during the pandemic of the treatment still in its experimental stage, and now the FDA granted the final approval for cases of hospitalized COVID-19 patients.

Doubts about its effectiveness

Remdesivir has allowed shorter recovery periods in some severe cases of COVID-19, although the World Health Organization (WHO) recently considered, after analyzing provisional data, that the antiviral as well as others that have been administered to COVID-19 patients, has an almost negligible impact on reducing mortality.

The main American epidemiologist, Dr. Anthony Fauci, has defended the use of Remdesivir, which is being administered to patients in the United States and with which the President of the United States was treated, Donald Trump, during his convalescence at the beginning of the month.

Single treatment

With the authorization received today, Remdesivir it becomes the only treatment authorized in the US for covid-19, which has infected more than 41 million people worldwide, although there are other treatments that already have emergency authorization such as the use of plasma.

“It is incredible that in less than a year since the first reports of infected by the disease known as COVID-19 in the United States, we have a treatment it is available to all patients who need it, “Gilead CEO Daniel O’Day said in a statement.

The pharmaceutical company expects to manufacture more than two million doses of treatment, which is administered intravenously, and multiply that production capacity during 2021.



Related Articles